Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose Ultibro Breezhaler vs ipratropium/salbutamol nebulizer in stable COPD
2015-000473-12Phase 4Completed
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic obstructive pulmonary disease (COPD) comparing Ultibro Breezhaler arm with Nebulized ipratropium/salbutamol arm (2 arms). Primary endpoint: FEV1 AUC 0-6h. Started Nov 2015; status: completed.
02
Drugs
indacaterol + glycopyrroniumipratropium bromidesalbutamol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2015-000473-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000473-12.